Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2

Mostrar otras versiones (1)

The global COVID-19 pandemic has sparked intense interest in the rapid development of vaccines as well as animal models to evaluate vaccine candidates and to define immune correlates of protection. We recently reported a mouse-adapted SARS-CoV-2 virus strain (MA10) with the potential to infect wild-...

Descripción completa

Detalles Bibliográficos
Autores principales: Tostanoski, Lisa H., Gralinski, Lisa E., Martinez, David R., Schaefer, Alexandra, Mahrokhian, Shant H., Li, Zhenfeng, Nampanya, Felix, Wan, Huahua, Yu, Jingyou, Chang, Aiquan, Liu, Jinyan, McMahan, Katherine, Ventura, John D., Dinnon, Kenneth H., Leist, Sarah R., Baric, Ralph S., Barouch, Dan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577371/
https://www.ncbi.nlm.nih.gov/pubmed/34523968
http://dx.doi.org/10.1128/JVI.00974-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577371/
https://www.ncbi.nlm.nih.gov/pubmed/34523968
http://dx.doi.org/10.1128/JVI.00974-21

Ejemplares similares